Published in Scand J Gastroenterol on December 01, 1995
Serum metabolomic profiling in acute alcoholic hepatitis identifies multiple dysregulated pathways. PLoS One (2014) 0.89
Systemic abnormalities in liver disease. World J Gastroenterol (2009) 0.78
Alterations in the erythrocyte plasma membranes in patients with alcohol-induced liver cirrhosis - preliminary results. Arch Med Sci (2011) 0.78
An unusual cause of anemia in cirrhosis: spur cell anemia, a case report with review of literature. Gastroenterol Hepatol Bed Bench (2016) 0.75
BRAF mutations in papillary thyroid carcinomas inhibit genes involved in iodine metabolism. J Clin Endocrinol Metab (2007) 1.93
Relation between serum uric acid and risk of cardiovascular disease in essential hypertension. The PIUMA study. Hypertension (2000) 1.87
Abnormal glucose counterregulation in insulin-dependent diabetes mellitus. Interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion. Diabetes (1983) 1.86
Reversibility of unawareness of hypoglycemia in patients with insulinomas. N Engl J Med (1993) 1.83
Androgen receptor mutations in prostate cancer. Cancer Res (2000) 1.74
Etiological diagnosis of primary adrenal insufficiency using an original flowchart of immune and biochemical markers. J Clin Endocrinol Metab (1998) 1.63
Association of MHC Class I chain-related A (MIC-A) gene polymorphism with Type I diabetes. Diabetologia (2000) 1.53
Effects of the short-acting insulin analog [Lys(B28),Pro(B29)] on postprandial blood glucose control in IDDM. Diabetes Care (1996) 1.46
Microsatellite polymorphism of the MHC class I chain-related (MIC-A and MIC-B) genes marks the risk for autoimmune Addison's disease. J Clin Endocrinol Metab (1999) 1.45
Cardiovascular response to exercise in diabetic patients: influence of autonomic neuropathy of different severity. Diabetologia (1995) 1.42
A reliable and reproducible test for adequate glucose counterregulation in type I diabetes mellitus. Diabetes (1984) 1.39
Efficacy and safety of pioglitazone versus metformin in patients with type 2 diabetes mellitus: a double-blind, randomized trial. J Clin Endocrinol Metab (2004) 1.39
Demonstration of a critical role for free fatty acids in mediating counterregulatory stimulation of gluconeogenesis and suppression of glucose utilization in humans. J Clin Invest (1993) 1.35
Correlation between B-RAFV600E mutation and clinico-pathologic parameters in papillary thyroid carcinoma: data from a multicentric Italian study and review of the literature. Endocr Relat Cancer (2006) 1.33
Long-term efficacy and tolerability of add-on pioglitazone therapy to failing monotherapy compared with addition of gliclazide or metformin in patients with type 2 diabetes. Diabetologia (2005) 1.29
Acute antihyperglycemic mechanisms of metformin in NIDDM. Evidence for suppression of lipid oxidation and hepatic glucose production. Diabetes (1994) 1.29
Mechanisms of glucagon secretion during insulin-induced hypoglycemia in man. Role of the beta cell and arterial hyperinsulinemia. J Clin Invest (1984) 1.21
Recommendations for the use of cardiovascular tests in diagnosing diabetic autonomic neuropathy. Nutr Metab Cardiovasc Dis (2011) 1.21
Long-term therapy with addition of pioglitazone to metformin compared with the addition of gliclazide to metformin in patients with type 2 diabetes: a randomized, comparative study. Diabetes Metab Res Rev (2005) 1.18
A long-term comparison of pioglitazone and gliclazide in patients with Type 2 diabetes mellitus: a randomized, double-blind, parallel-group comparison trial. Diabet Med (2005) 1.17
The dawn phenomenon in type 1 (insulin-dependent) diabetes mellitus: magnitude, frequency, variability, and dependency on glucose counterregulation and insulin sensitivity. Diabetologia (1991) 1.16
Circulating insulin and insulin growth factor-1 are independent determinants of left ventricular mass and geometry in essential hypertension. Circulation (1999) 1.15
High diagnostic accuracy for idiopathic Addison's disease with a sensitive radiobinding assay for autoantibodies against recombinant human 21-hydroxylase. J Clin Endocrinol Metab (1995) 1.14
X-linked adrenoleukodystrophy is a frequent cause of idiopathic Addison's disease in young adult male patients. J Clin Endocrinol Metab (1996) 1.14
Demonstration of a dawn phenomenon in normal human volunteers. Diabetes (1984) 1.10
Biochemical and molecular characterization of the novel BRAF(V599Ins) mutation detected in a classic papillary thyroid carcinoma. Oncogene (2006) 1.02
Modification of glycosylated haemoglobin concentration during artificial endocrine pancreas treatment of diabetics. Evidence for a short-term effect on HbA 1 (a+b+c) levels. Diabetologia (1980) 1.01
Evidence of increased systemic glucose production and gluconeogenesis in an early stage of NIDDM. Diabetes (1997) 1.00
Fusion of human sperm to prostasomes at acidic pH. J Membr Biol (1997) 1.00
Autoantibody recognition of COOH-terminal epitopes of GAD65 marks the risk for insulin requirement in adult-onset diabetes mellitus. J Clin Endocrinol Metab (2000) 1.00
Better long-term glycaemic control with the basal insulin glargine as compared with NPH in patients with Type 1 diabetes mellitus given meal-time lispro insulin. Diabet Med (2004) 1.00
Physiological increments in plasma insulin concentrations have selective and different effects on synthesis of hepatic proteins in normal humans. Diabetes (1993) 0.99
Effect of storage temperature of insulin on pharmacokinetics and pharmacodynamics of insulin mixtures injected subcutaneously in subjects with type 1 (insulin-dependent) diabetes mellitus. Diabetologia (1988) 0.97
Improved insulin action and glycemic control after long-term angiotensin-converting enzyme inhibition in subjects with arterial hypertension and type II diabetes. Diabetes Care (1993) 0.96
Adrenergic mechanisms contribute to the late phase of hypoglycemic glucose counterregulation in humans by stimulating lipolysis. J Clin Invest (1992) 0.95
Influence of autonomic neuropathy of different severities on the hypercapnic drive to breathing in diabetic patients. Chest (1997) 0.95
Optimized parameters for microencapsulation of pancreatic islet cells: an in vitro study clueing on islet graft immunoprotection in type 1 diabetes mellitus. Transpl Immunol (2004) 0.95
Contribution of cortisol to glucose counterregulation in humans. Am J Physiol (1989) 0.94
Standard technical procedures for microencapsulation of human islets for graft into nonimmunosuppressed patients with type 1 diabetes mellitus. Transplant Proc (2006) 0.93
Contribution of amino acids and insulin to protein anabolism during meal absorption. Diabetes (1996) 0.93
Role of human prostasomes in the activation of spermatozoa. J Cell Mol Med (2004) 0.93
Transplantation of pancreatic islets contained in minimal volume microcapsules in diabetic high mammalians. Ann N Y Acad Sci (1999) 0.92
Lack of glucagon response in glucose counter-regulation in type 1 (insulin-dependent) diabetics: absence of recovery after prolonged optimal insulin therapy. Diabetologia (1982) 0.92
Studies on overnight insulin requirements and metabolic clearance rate of insulin in normal and diabetic man: relevance to the pathogenesis of the dawn phenomenon. Diabetologia (1986) 0.91
Nocturnal spikes of growth hormone secretion cause the dawn phenomenon in type 1 (insulin-dependent) diabetes mellitus by decreasing hepatic (and extrahepatic) sensitivity to insulin in the absence of insulin waning. Diabetologia (1990) 0.90
Use of the short-acting insulin analogue lispro in intensive treatment of type 1 diabetes mellitus: importance of appropriate replacement of basal insulin and time-interval injection-meal. Diabet Med (1998) 0.89
The effect of asymptomatic nocturnal hypoglycemia on glycemic control in diabetes mellitus. N Engl J Med (1988) 0.89
The adrenergic contribution to glucose counterregulation in type I diabetes mellitus. Dependency on A-cell function and mediation through beta 2-adrenergic receptors. Diabetes (1983) 0.88
Effectiveness of frequency-modulated electromagnetic neural stimulation in the treatment of painful diabetic neuropathy. Diabetologia (2005) 0.88
Long-term intensive treatment of type 1 diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtime. Diabetes Care (1999) 0.87
Prostasome to sperm transfer of CD13/aminopeptidase N (EC 3.4.11.2). Biochim Biophys Acta (1997) 0.87
Increased risk for endocrine autoimmunity in Italian type 2 diabetic patients with GAD65 autoantibodies. Clin Endocrinol (Oxf) (2000) 0.87
Continuous subcutaneous insulin infusion treatment in insulin-dependent diabetic patients: a comparison with conventional optimized treatment in a long-term study. Diabetes Care (1984) 0.87
Fatty acid pattern of human prostasome lipid. Arch Biochem Biophys (1998) 0.87
Role of hepatic autoregulation in defense against hypoglycemia in humans. J Clin Invest (1985) 0.86
Contribution of autonomic neuropathy to reduced plasma adrenaline responses to hypoglycemia in IDDM: evidence for a nonselective defect. Diabetes (1997) 0.86
Mechanisms of arterial hypotension after therapeutic dose of subcutaneous insulin in diabetic autonomic neuropathy. Diabetes (1993) 0.86
Rate of fall of blood glucose and physiological responses of counterregulatory hormones, clinical symptoms and cognitive function to hypoglycaemia in Type I diabetes mellitus in the postprandial state. Diabetologia (2002) 0.86
Impairment of the respiratory system in diabetic autonomic neuropathy. Diabetes Nutr Metab (2000) 0.85
Effect of cigarette smoking and of a transdermal nicotine delivery system on glucoregulation in type 2 diabetes mellitus. Eur J Clin Pharmacol (1992) 0.85
Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function. Diabetes Care (1995) 0.85
21-hydroxylase autoantibodies in adult patients with endocrine autoimmune diseases are highly specific for Addison's disease. Belgian Diabetes Registry. Clin Exp Immunol (1997) 0.84
Pharmacokinetics, pharmacodynamics and glucose counterregulation following subcutaneous injection of the monomeric insulin analogue [Lys(B28),Pro(B29)] in IDDM. Diabetologia (1994) 0.84
The importance of determining irreversibly glycosylated hemoglobin in diabetics. Diabetes (1981) 0.84
Suppressive effect of long term sulfonylurea treatment on A, B, and D cells of normal rat pancreas. Endocrinology (1983) 0.84
Prostasome-like particles in stallion semen. Biol Reprod (1998) 0.84
Progesterone-induced increase of sperm cytosolic calcium is enhanced by previous fusion of spermatozoa to prostasomes. Cell Calcium (2001) 0.84
[Evoked acoustic oto-emissions in patients with diabetes mellitus]. Ann Otolaryngol Chir Cervicofac (1993) 0.83
M. avium binding to HLA-DR expressed alleles in silico: a model of phenotypic susceptibility to sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis (2008) 0.83
Regulation of MDM4 (MDMX) function by p76(MDM2): a new facet in the control of p53 activity. Oncogene (2010) 0.83
The motility of human spermatozoa as influenced by prostasomes at various pH levels. Biol Cell (1999) 0.83
Comparison of glycaemic control over 1 year with pioglitazone or gliclazide in patients with Type 2 diabetes. Diabet Med (2006) 0.83
Two distinct MICA gene markers discriminate major autoimmune diabetes types. J Clin Endocrinol Metab (2001) 0.82
Optimal feedback glycaemia regulation in diabetics. Med Biol Eng Comput (1982) 0.82
Contribution of postprandial versus interprandial blood glucose to HbA1c in type 1 diabetes on physiologic intensive therapy with lispro insulin at mealtime. Diabetes Care (1999) 0.82
Modest decrements in plasma glucose concentration cause early impairment in cognitive function and later activation of glucose counterregulation in the absence of hypoglycemic symptoms in normal man. J Clin Invest (1988) 0.82
Long-term intensive therapy of IDDM patients with clinically overt autonomic neuropathy: effects on hypoglycemia awareness and counterregulation. Diabetes (1997) 0.82
Demonstration of a role for growth hormone in glucose counterregulation. Am J Physiol (1989) 0.82
ACE-inhibition increases hepatic and extrahepatic sensitivity to insulin in patients with type 2 (non-insulin-dependent) diabetes mellitus and arterial hypertension. Diabetologia (1991) 0.82
Cytotoxic effects of a novel pyrazolopyrimidine derivative entrapped in liposomes in anaplastic thyroid cancer cells in vitro and in xenograft tumors in vivo. Endocr Relat Cancer (2008) 0.82
Efficacy and safety of acarbose in the treatment of Type 1 diabetes mellitus: a placebo-controlled, double-blind, multicentre study. Diabet Med (1999) 0.81
Neurohumoral control of gallbladder motility in healthy subjects and diabetic patients with or without autonomic neuropathy. Dig Dis Sci (1990) 0.81
Improved function of rat islets upon co-microencapsulation with Sertoli's cells in alginate/poly-L-ornithine. AAPS PharmSciTech (2001) 0.81
Counterregulatory hormones during moderate, insulin-induced, blood glucose decrements in man. J Clin Endocrinol Metab (1981) 0.81
Increase of human spermatozoa intracellular Ca2+ concentration after fusion with prostasomes. Cell Calcium (1999) 0.80
Ventilatory response to exercise in diabetic subjects with autonomic neuropathy. J Appl Physiol (1985) (1996) 0.80
Evaluation of goiter using ultrasound criteria: a survey in a middle schoolchildren population of a mountain area in Central Italy. J Endocrinol Invest (2006) 0.80
Alginate/polyaminoacidic coherent microcapsules for pancreatic islet graft immunoisolation in diabetic recipients. Ann N Y Acad Sci (1997) 0.80
Coherent microcapsules for pancreatic islet transplantation: a new approach for bioartificial pancreas. Transplant Proc (1996) 0.80
Contribution of obesity to insulin resistance in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab (1995) 0.80
Effect of metabolic control on urinary excretion and plasma levels of catecholamines in diabetics. Horm Metab Res (1979) 0.80
Effects of metformin therapy on plasma amino acid pattern in patients with maturity-onset diabetes. Drugs Exp Clin Res (1989) 0.80
The pancreatic-adrenocortical-pituitary clamp technique for study of counterregulation in humans. Am J Physiol (1987) 0.80